AVDL

Avadel Pharmaceuticals

112 hedge funds and large institutions have $806M invested in Avadel Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
112
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$15.6M
Puts
$4.96M
Net Calls
Net Calls Change

Top Buyers

1 +$31.6M
2 +$21.8M
3 +$11M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$6.88M
5
ABG
Ally Bridge Group
New York
+$4.9M

Top Sellers

1 -$21.2M
2 -$9.83M
3 -$5.71M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.98M
5
Marshall Wace
Marshall Wace
United Kingdom
-$4.32M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$4.04M
27
$3.56M
28
$3.18M
29
$2.89M
30
$2.78M
31
$2.18M
32
$2.12M
33
$1.74M
34
$1.55M
35
$1.51M
36
$1.5M
37
$1.48M
38
$1.36M
39
$1.31M
40
$1.19M
41
$1.15M
42
$1.13M
43
$1.13M
44
$1.06M
45
$1.05M
46
$919K
47
$898K
48
$892K
49
$887K
50
$840K